Samantha L. Burton

T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

Prabhu S. Arunachalam, Tysheena P. Charles, Vineet Joag et al. · Nature Medicine · 2020 · 170 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques

Sudhir Pai Kasturi, Pamela A. Kozlowski, Helder I. Nakaya et al. · Journal of Virology · 2016 · 81 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection

Tysheena P. Charles, Samantha L. Burton, Prabhu S. Arunachalam et al. · PLoS Pathogens · 2021 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth

S. Abigail Smith, Samantha L. Burton, William Kilembe et al. · PLoS Pathogens · 2016 · 31 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120

S. Abigail Smith, Samantha L. Burton, William Kilembe et al. · Frontiers in Immunology · 2019 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17